Search research articles
Contact Us
Filters
Showing results (201-210 of 721) with videos related to
Page
of 73
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2022
Radioiodine Ablation of Thyroid Remnants in Patients with Graves' Orbitopathy
Michael Oeverhaus, Jana Koenen, Nikolaos Bechrakis, et al.
Endocrine
|
January 2, 2019
Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases
Christian Happel, Wolfgang Tilman Kranert, Hanns Ackermann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 7, 2021
Factors predicting biochemical response and survival benefits following radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review
Reyhaneh Manafi-Farid, Sara Harsini, Bahare Saidi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 2, 2023
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives
David Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, et al.
Theranostics
|
July 21, 2020
Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving <sup>177</sup>Lu-PSMA-617 Radioligand Therapy
Robert Seifert, Konstantin Seitzer, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 10, 2023
Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?
Rayjanah Allie, Irfan Kayani, Gopinath Gnanasegaran, et al.
EJNMMI Research
|
May 16, 2015
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Constantin Lapa, Rudolf A Werner, Christina Bluemel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2005
2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy
Heiko Schöder, Ken Herrmann, Mithat Gönen, et al.
Cancers
|
July 9, 2022
Intra-Individual Comparison of <sup>124</sup>I-PET/CT and <sup>124</sup>I-PET/MR Hybrid Imaging of Patients with Resected Differentiated Thyroid Carcinoma: Aspects of Attenuation Correction
Hong Grafe, Maike E Lindemann, Manuel Weber, et al.
Theranostics
|
April 1, 2015
Radionuclide imaging of neurohormonal system of the heart
Xinyu Chen, Rudolf A Werner, Mehrbod S Javadi, et al.
Page
of 73
Search research articles
Search
Showing results (201-210 of 721) with videos related to
Sort By:
Page
of 73
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 23, 2022
Radioiodine Ablation of Thyroid Remnants in Patients with Graves' Orbitopathy
Michael Oeverhaus, Jana Koenen, Nikolaos Bechrakis, et al.
Endocrine
|
January 2, 2019
Thyroid stunning in radioiodine-131 therapy of benign thyroid diseases
Christian Happel, Wolfgang Tilman Kranert, Hanns Ackermann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
March 7, 2021
Factors predicting biochemical response and survival benefits following radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA in metastatic castrate-resistant prostate cancer: a review
Reyhaneh Manafi-Farid, Sara Harsini, Bahare Saidi, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 2, 2023
Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives
David Kersting, Ilektra-Antonia Mavroeidi, Stephan Settelmeier, et al.
Theranostics
|
July 21, 2020
Analysis of PSMA expression and outcome in patients with advanced Prostate Cancer receiving <sup>177</sup>Lu-PSMA-617 Radioligand Therapy
Robert Seifert, Konstantin Seitzer, Ken Herrmann, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 10, 2023
Strategy planning for turbulent times in nuclear medicine: Time to begin at the beginning?
Rayjanah Allie, Irfan Kayani, Gopinath Gnanasegaran, et al.
EJNMMI Research
|
May 16, 2015
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapy
Constantin Lapa, Rudolf A Werner, Christina Bluemel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 8, 2005
2-[18F]fluoro-2-deoxyglucose positron emission tomography for the detection of disease in patients with prostate-specific antigen relapse after radical prostatectomy
Heiko Schöder, Ken Herrmann, Mithat Gönen, et al.
Cancers
|
July 9, 2022
Intra-Individual Comparison of <sup>124</sup>I-PET/CT and <sup>124</sup>I-PET/MR Hybrid Imaging of Patients with Resected Differentiated Thyroid Carcinoma: Aspects of Attenuation Correction
Hong Grafe, Maike E Lindemann, Manuel Weber, et al.
Theranostics
|
April 1, 2015
Radionuclide imaging of neurohormonal system of the heart
Xinyu Chen, Rudolf A Werner, Mehrbod S Javadi, et al.
Page
of 73